Table 2.
Summary of reported infection and revision rates of included studies.
| Authors & Year | Total infection (%) |
HIV+ infection (%) |
HIV– infection (%) |
Total revision (%) |
HIV+ revision (%) |
HIV- revision (%) |
|---|---|---|---|---|---|---|
| Mahure et al. 2017(11) | 0.14 | 0.36 | 0.14 | N/A | N/A | N/A |
| Zhao et al. 2015(12) | 0 | 0 | 0 | 0 | 0 | 0 |
| Lin et al. 2014(13) | 12.5 | 9.1 | 5.58 | 5.58 | 9.1 | 5.38 |
| Lin et al. 2013(14) | 0.33** | 0.6** | 0.33** | N/A | N/A | N/A |
| Issa et al. 2013(15) | 2.46 | 4.55 | 1.28 | 4.1 | 6.82 | 2.56 |
| Capogna et al. 2013(16) | 1.93 | 4.4 | 0.72 | 2.42 | 5.8 | 0.72 |
| Tornero et al. 2012(17) | 3.7 | 0 | 5.56 | 1.85 | 0 | 2.78 |
| Rodriguez-Merchan et al. 2011(18) | 6.98 | 9.52 | 4.55 | 6.98 | 9.52 | 4.55 |
| Goddard et al. 2010(19) | 1.43 | 5.88 | 0 | 10 | - | - |
| Lubega et al. 2009(20) | 0 | 0 | 0 | 2.74 | - | - |
| Solimeno et al. 2009(21) | 7.76 | 9.09 | 7.23 | 13.79 | - | - |
| Powell et al. 2005(22) | 9.8 | 10 | 9.52 | 7.84 | 6.67 | 9.52 |
| Silva et al. 2005(23) | 15.56 | 16.67# | 13.33 | 13.33 | - | - |
| Norian et al. 2002(24) | 13.2 | 10 | 25 | 18.87* | 20* | 25* |
| Lehman et al. 2001(3) | 19.51 | 18.18 | 25 | 21.95 | 21.21 | 25 |
| Thomason et al. 1999(25) | 17.39° | 10.53° | 50*** | 8.7 | - | - |
| Vastel et al. 1999(26) | 20.69 | 31.25 | 7.69 | 17.24 | - | - |
| Lofqvist et al. 1996(27) | 15.38 | 50# | 0 | 30.77 | 75 | 11.11 |
| Kelley et al. 1995(28) | 8.82 | 18.75° | 0 ser/ukn° | 29.41 | - | - |
°Reported as patients; N/A, Not applicable; -Not stated; ser/unkseronegative or unknown
#Assumed seropositive at time of surgery
*Defined as “failure”
**In-hospital follow-up only
***Assumed seronegative.